Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients.
Laracy JC, Yan J, Steiger SN, Tan CA, Cohen N, Robilotti EV, Fender J, Cohen S, Korde N, Lee-Teh M, Noy A, Oved JH, Roeker LE, Shah G, Babady NE, Kamboj M, Seo SK. Laracy JC, et al. Among authors: korde n. Haematologica. 2023 Nov 1;108(11):3058-3067. doi: 10.3324/haematol.2023.283015. Haematologica. 2023. PMID: 37345467 Free PMC article.
Second malignancies after multiple myeloma: from 1960s to 2010s.
Thomas A, Mailankody S, Korde N, Kristinsson SY, Turesson I, Landgren O. Thomas A, et al. Among authors: korde n. Blood. 2012 Mar 22;119(12):2731-7. doi: 10.1182/blood-2011-12-381426. Epub 2012 Feb 6. Blood. 2012. PMID: 22310913 Free PMC article. Review.
Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial.
Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, Korde N, Minter AR, Weiss BM, Mena E, Lindenberg L, Aras O, Purdue MP, Hofmann JN, Steinberg SM, Calvo KR, Choyke PL, Maric I, Kurdziel K, Landgren O. Bhutani M, et al. Among authors: korde n. Leukemia. 2014 Feb;28(2):413-6. doi: 10.1038/leu.2013.268. Epub 2013 Sep 18. Leukemia. 2014. PMID: 24045500 Free PMC article. Clinical Trial. No abstract available.
Pursuing the curative blueprint for early myeloma.
Roschewski M, Korde N, Wu SP, Landgren O. Roschewski M, et al. Among authors: korde n. Blood. 2013 Jul 25;122(4):486-90. doi: 10.1182/blood-2013-01-481291. Epub 2013 Jun 19. Blood. 2013. PMID: 23782936 Free PMC article.
A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma.
Holkova B, Zingone A, Kmieciak M, Bose P, Badros AZ, Voorhees PM, Baz R, Korde N, Lin HY, Chen JQ, Herrmann M, Xi L, Raffeld M, Zhao X, Wan W, Tombes MB, Shrader E, Weir-Wiggins C, Sankala H, Hogan KT, Doyle A, Annunziata CM, Wellons M, Roberts JD, Sullivan D, Landgren O, Grant S. Holkova B, et al. Among authors: korde n. Clin Cancer Res. 2016 Mar 1;22(5):1067-75. doi: 10.1158/1078-0432.CCR-15-1076. Epub 2015 Oct 7. Clin Cancer Res. 2016. PMID: 26446942 Free PMC article. Clinical Trial.
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study.
Cherry BM, Korde N, Kwok M, Manasanch EE, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Maric I, Calvo KR, Braylan R, Stetler-Stevenson M, Yuan C, Tembhare P, Zingone A, Costello R, Roschewski MJ, Landgren O. Cherry BM, et al. Among authors: korde n. Leuk Lymphoma. 2013 Oct;54(10):2215-8. doi: 10.3109/10428194.2013.764419. Epub 2013 Jul 29. Leuk Lymphoma. 2013. PMID: 23311294 Free PMC article.
115 results